Fennec Pharmaceuticals Inc (FENC)
7.04
-0.08
(-1.12%)
USD |
NASDAQ |
May 17, 16:00
7.04
0.00 (0.00%)
After-Hours: 20:00
Fennec Pharmaceuticals Net Income (Quarterly): -2.682M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.682M |
| September 30, 2023 | -1.867M |
| June 30, 2023 | -5.444M |
| March 31, 2023 | -6.052M |
| December 31, 2022 | -6.857M |
| September 30, 2022 | -8.089M |
| June 30, 2022 | -5.072M |
| March 31, 2022 | -3.696M |
| December 31, 2021 | -4.427M |
| September 30, 2021 | -4.185M |
| June 30, 2021 | -4.001M |
| March 31, 2021 | -4.733M |
| December 31, 2020 | -3.238M |
| September 30, 2020 | -6.20M |
| June 30, 2020 | -4.845M |
| March 31, 2020 | -3.826M |
| December 31, 2019 | -3.61M |
| September 30, 2019 | -1.809M |
| June 30, 2019 | -4.73M |
| March 31, 2019 | -2.626M |
| December 31, 2018 | -2.984M |
| September 30, 2018 | -2.749M |
| June 30, 2018 | -2.587M |
| March 31, 2018 | -1.568M |
| December 31, 2017 | -2.29M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.352M |
| June 30, 2017 | -1.598M |
| March 31, 2017 | -0.806M |
| December 31, 2016 | -1.143M |
| September 30, 2016 | -0.502M |
| June 30, 2016 | -0.724M |
| March 31, 2016 | -0.42M |
| December 31, 2015 | -0.54M |
| September 30, 2015 | -0.123M |
| June 30, 2015 | -0.173M |
| March 31, 2015 | 0.177M |
| December 31, 2014 | 1.388M |
| September 30, 2014 | 0.38M |
| June 30, 2014 | -0.75M |
| March 31, 2014 | -3.194M |
| December 31, 2013 | 1.111M |
| September 30, 2013 | -1.766M |
| June 30, 2013 | 6.607M |
| March 31, 2013 | -4.108M |
| December 31, 2012 | -6.511M |
| September 30, 2012 | -0.764M |
| June 30, 2012 | -0.602M |
| March 31, 2012 | 2.715M |
| December 31, 2011 | 3.509M |
| September 30, 2011 | -3.144M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-8.089M
Minimum
Sep 2022
-1.809M
Maximum
Sep 2019
-4.493M
Average
-4.427M
Median
Dec 2021
Net Income (Quarterly) Benchmarks
| Cutera Inc | -22.78M |
| Durect Corp | -7.643M |
| Harrow Inc | -13.56M |
| OptiNose Inc | -14.07M |
| Treace Medical Concepts Inc | -18.68M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 9.735M |
| Total Expenses (Quarterly) | 11.62M |
| EPS Diluted (Quarterly) | -0.10 |
| Enterprise Value | 210.61M |
| Gross Profit Margin (Quarterly) | 92.96% |
| Profit Margin (Quarterly) | -27.55% |
| Earnings Yield | -8.66% |
| Normalized Earnings Yield | -8.647 |